文献速递腹部泌尿生殖CT

平扫CT上的肾癌:影像特征、检出率与结局

Renal cancer at unenhanced CT: imaging features, detection rates, and outcomes.
PubMed 文献 · Abdom Radiol (NY) · 2018-01-01

回顾性分析2000至2005年间在本机构接受腹部平扫CT的15695例患者,82例(0.52%)随后诊断为肾癌;其中43例(52%)在首次平扫CT上可回顾性识别,63%(27/43)被原始报告检出,37%(16/43)漏诊;仅肿瘤大小与检出相关,>3.0 cm者检出率83%(20/24),≤3.0 cm者37%(7/19)(p=0.0036)。

要点

  • 平扫CT上肾癌检出率低,可回顾性识别的肾癌中37%(16/43)被漏诊。
  • 肿瘤大小是唯一与检出相关的特征:>3.0 cm检出率83%(20/24),≤3.0 cm为37%(7/19)(p=0.0036)。
  • 漏诊肾癌在诊断前中位33.5个月内无转移,但4例(25%)分期进展。

核心结论

  • 平扫腹部CT上肾癌罕见;可回顾性识别的潜在可检出肾癌中超过三分之一被前瞻性漏诊;漏诊肾癌未发生转移,但少数(4/16,25%)在诊断前分期进展。

研究设计与样本

  • 回顾性、符合HIPAA的研究,经机构审查委员会批准;回顾2000至2005年间在本机构接受腹部平扫CT的所有患者电子健康记录,识别随访至多12年内随后诊断为肾癌的患者;回顾图像判断肾癌在首次平扫CT上是否可见并记录表现;回顾原始放射学报告判断是否报告肾癌;采用Fisher精确检验比较检出与漏诊肾癌的影像特征;以诊断时间及诊断时分期评估漏诊的潜在影响。

关键影像表现/征象

  • 可回顾性识别的肾癌中63%(27/43)在首次平扫CT上被原始检出并报告,37%(16/43)被漏诊。
  • 肿瘤大小是唯一与检出相关的特征:>3.0 cm的肾癌检出率83%(20/24),≤3.0 cm的肾癌检出率37%(7/19)(p=0.0036)。

诊断标准与关键数值

  • 检出率以原始放射学报告是否报告肾癌判定:可回顾性识别的肾癌中63%(27/43)被检出,37%(16/43)被漏诊。
  • 肿瘤大小分组以3.0 cm为界:>3.0 cm检出率83%(20/24),≤3.0 cm检出率37%(7/19)(p=0.0036)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To describe and quantify the rate of detection of renal cancer on unenhanced CT.

METHODS: This retrospective, HIPAA-compliant study was approved by the Institutional Review Board. Electronic health records for all patients who underwent unenhanced abdominal CT at our institution between 2000 and 2005 were reviewed to identify patients subsequently diagnosed with renal cancer during a follow-up period of up to 12 years. Images were reviewed to determine if the cancer was visible at index (first) unenhanced CT and their findings recorded. Original radiology reports were reviewed to determine whether the renal cancer was reported; Fisher's Exact Test compared imaging features of detected and missed cancers. Clinical outcomes including time until diagnosis and stage at diagnosis were used to assess the potential impact of missed cancers.

RESULTS: Of 15,695 patients, 82 (0.52%) were diagnosed with renal cancer. Of these, 43/82 (52%) cancers were retrospectively detectable on index unenhanced CT. Among retrospectively detectable cancers, 63% (27/43) were originally detected and reported on index CT and 37% (16/43) were missed. Size was the only feature associated with detection; 83% (20/24) of cancers > 3.0 cm were detected versus 37% (7/19) of cancers ≤ 3.0 cm (p = 0.0036). Although none of the 16 missed renal cancers developed metastases between index CT and time of diagnosis (median 33.5 months), 4 (25%) progressed in stage.

CONCLUSIONS: Renal cancer was rare in patients undergoing unenhanced abdominal CT. Over one-third of potentially detectable cancers were missed prospectively. However, missed cancers did not metastasize and infrequently progressed in stage before being diagnosed.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. O'Connor SD, Silverman SG, Cochon LR, et al. Renal cancer at unenhanced CT: imaging features, detection rates, and outcomes. Abdom Radiol (NY). 2018. PMID: 29128991. doi:10.1007/s00261-017-1376-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。